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Background
Liver resection is a curative treatment for hepatocellular
carcinoma (HCC) [1]. Its role for the elderly remains
undefined. In addition to surgery, percutaneous proce-
dures have recently been proposed [2,3]. The choice of
surgical and non-surgical therapy closely depends on the
liver functional reserve and pre-existing co-morbidities.
Materials and methods
A retrospective analysis of a geriatric population (≥ 65
years) with HCC was proposed (July 2000-September
2009). Morbidity, survival, and recurrence rate were
evaluated.
Results
A cohort of 45 Child-Pugh class A or B patients was
collected. Of these, twenty-seven underwent surgery
(male/female, 22/5; mean age 70). For 18 cases trans-
catheter arterial embolization (TACE), radiofrequency
ablation (RFA), and portal vein embolization (PVE)
(male/female, 15/3; mean age 74) were indicated (see
Figure 1). Twenty patients with hepatitis C infection, 7
with hepatitis B infection, 2 with both infections, 2 with
alcoholic disease, and 14 with unknown etiology. The
mean tumor size in the surgical group was 4.41 cm,
range 1,2 -12 cm; in the non-surgical cohort the size
was 6,31 cm, range 3-11,5 cm. Twenty-eight unifocal
and 17 multinodular tumors. We reported the amino-
transferase serum variation after surgery and the tumor
histology (see Figure 2). One patient died from liver fail-
ure. Nonlethal complications occurred in 21 patients.
One case of biliary fistula and 1 intra-abdominal bleed-
ing. The mean overall survival after surgery was 50
months. For ablative procedures was 26 months. The
disease-free survival was in media 32 months the for
surgical group and 18 months for the non-surgical
group. Kaplan-Meier curves show the statistical signifi-
cance (see Figure 3).
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Figure 1 Type of surgical and non-surgical treatment options in our experience. Percutaneous procedures: radiofrequency ablation (RFA);
transcatheter arterial embolization (TACE); portal vein embolization (PVE) (a, b).
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The role of liver resection for HCC is debated in the
elderly. This is related to the short life expectancy and
improvement of percutaneous procedures. These seem
to guarantee similar overall survival compared to
surgery. Unfortunately, this was not demonstrated from
our data. With the improvement of surgical and
anesthesia support, mortality has been significantly
reduced. We performed liver resections in selected cases
and our experience confirms the surgical benefits in
elderly population.
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Figure 2 Pathologic features of HCC specimens. In the majority of cases, tumor has showed a mild differentiated growth pattern (a).
Perioperative laboratory values of liver damage: the mean Aspartate aminotrasferase (AST) and alanine aminotrasferase (ALT) serum level
detected during pre-operative time and post-operative day 1, 3, and 7 (b).
Figure 3 Kaplan-Meier overall survival and disease-free survival curves for HCC in elderly patients: surgical and non-surgical groups.
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